Bogart Wealth LLC’s Meridian Bioscience Inc VIVO Stock Holding History

Bogart Wealth LLC’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25	Closed	-$830	–	1229
2022 Q4	$830	Buy	+25	New	+$805	﹤0.01%	875

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bogart Wealth LLC's VIVO Position: Q1 2023 in Review

Bogart Wealth LLC sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 25 shares — an estimated $830 sold.

Bogart Wealth LLC first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $830 in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Bogart Wealth LLC reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Bogart Wealth LLC sold 25 Meridian Bioscience Inc shares in Q1 2023, an estimated $830.
Bogart Wealth LLC first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Bogart Wealth LLC's Meridian Bioscience Inc position peaked at $830 in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Bogart Wealth LLC's 13F filing for Q1 2023, filed 21 Apr 2023.